Phase 1 Study(Additional) of URC102 in Healthy Subjects

NCT02524678 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Placebo
DRUG: URC102

Sponsor

JW Pharmaceutical